Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00555347 · ClinicalTrials.gov registry record · Phase 2
Use of Armodafinil for Fatigue in Sarcoidosis
A Phase 2 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00555347 is a Phase 2 study that has completed, run by University of Cincinnati. The registered enrollment target is 20 participants.
The verdict
NCT00555347, a Phase 2 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine the effect of Armodafinil (Nuvigil) on fatigue and sleep in sarcoidosis.
Interventions
- DRUG Placebo
- DRUG Armodafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00555347
The ClinicalTrials.gov registry entry for NCT00555347 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00555347 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00555347 about?
NCT00555347 is a clinical study titled "Use of Armodafinil for Fatigue in Sarcoidosis". To determine the effect of Armodafinil (Nuvigil) on fatigue and sleep in sarcoidosis.
What is the current status of trial NCT00555347?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2007-10. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00555347?
The interventions under investigation include: Placebo (DRUG), Armodafinil (DRUG).
Who is sponsoring clinical trial NCT00555347?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.